Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ADV-TK Adjuvant Therapy in Liver Transplantation for Advanced HCC
NCT02202564Phase 2Completed
- Sponsor
- Huazhong University of Science and Technology
- Start
- Oct 2006
- Primary completion
- Oct 2011
- Modality
- Gene Editing, Gene Silencing, Oncolytic Viruses
01
Overview
A Phase 2 trial of aglatimagene besadenovec in hepatocellular carcinoma (HCC), sponsored by Huazhong University of Science and Technology. Started Oct 2006; status: completed.
02
Drugs
aglatimagene besadenovec
03
Conditions
hepatocellular carcinoma (HCC)
Beyond the preview
Go deeper on NCT02202564.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02202564.